These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26675223)

  • 1. Delivery of Peptides Via the Oral Route: Diabetes Treatment by Peptide-Loaded Nanoparticles.
    Bouttefeux O; Beloqui A; Preat V
    Curr Pharm Des; 2016; 22(9):1161-76. PubMed ID: 26675223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel strategies in the oral delivery of antidiabetic peptide drugs - Insulin, GLP 1 and its analogs.
    Ismail R; Csóka I
    Eur J Pharm Biopharm; 2017 Jun; 115():257-267. PubMed ID: 28336368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments.
    Krol S; Ellis-Behnke R; Marchetti P
    Nanomedicine; 2012 Sep; 8 Suppl 1():S69-76. PubMed ID: 22640905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the efficacy and safety of nanoparticle-based oral insulin delivery systems.
    Card JW; Magnuson BA
    Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G956-67. PubMed ID: 21921287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment.
    Wong CY; Al-Salami H; Dass CR
    J Control Release; 2017 Oct; 264():247-275. PubMed ID: 28887133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments.
    Krol S; Ellis-Behnke R; Marchetti P
    Maturitas; 2012 Sep; 73(1):61-7. PubMed ID: 22209199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.
    Tyagi P; Subramony JA
    J Control Release; 2018 Feb; 272():159-168. PubMed ID: 29355619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral insulin delivery: how far are we?
    Fonte P; Araújo F; Reis S; Sarmento B
    J Diabetes Sci Technol; 2013 Mar; 7(2):520-31. PubMed ID: 23567010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of polysaccharides from natural resources to design oral insulin micro- and nanoparticles intended for the treatment of Diabetes mellitus: A review.
    Meneguin AB; Silvestre ALP; Sposito L; de Souza MPC; Sábio RM; Araújo VHS; Cury BSF; Chorilli M
    Carbohydr Polym; 2021 Mar; 256():117504. PubMed ID: 33483027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Brief Overview of the Oral Delivery of Insulin as an Alternative to the Parenteral Delivery.
    Macedo A; Filipe P; Thomé NG; Vieira J; Oliveira C; Teodósio C; Ferreira R; Roque L; Fonte P
    Curr Mol Med; 2020; 20(2):134-143. PubMed ID: 31965934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Diabetes.
    Rao PV; Gan SH
    Curr Drug Metab; 2015; 16(5):371-5. PubMed ID: 25429672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral insulin delivery: existing barriers and current counter-strategies.
    Gedawy A; Martinez J; Al-Salami H; Dass CR
    J Pharm Pharmacol; 2018 Feb; 70(2):197-213. PubMed ID: 29193053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing diabetes with nanomedicine: challenges and opportunities.
    Veiseh O; Tang BC; Whitehead KA; Anderson DG; Langer R
    Nat Rev Drug Discov; 2015 Jan; 14(1):45-57. PubMed ID: 25430866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of antidiabetic drugs: formulation and delivery strategies.
    Ahad A; Al-Saleh AA; Akhtar N; Al-Mohizea AM; Al-Jenoobi FI
    Drug Discov Today; 2015 Oct; 20(10):1217-27. PubMed ID: 26100737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery.
    Azevedo C; Pinto S; Benjakul S; Nilsen J; Santos HA; Traverso G; Andersen JT; Sarmento B
    Adv Drug Deliv Rev; 2021 Aug; 175():113778. PubMed ID: 33887405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis.
    Luo XM; Yan C; Feng YM
    Adv Drug Deliv Rev; 2021 May; 172():234-248. PubMed ID: 33417981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances of polysaccharide-based nanoparticles for oral insulin delivery.
    Hu Q; Luo Y
    Int J Biol Macromol; 2018 Dec; 120(Pt A):775-782. PubMed ID: 30170057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.